Title: Metformin and insulin sensitizerrosiglitazone combination in improving nonalcoholic fatty liver disease
Abstract: Objective to study the combined use of metformin and insulin sensitizer rosiglitazone to improve nonalcoholic fatty liver disease(NAFLD).Method Eight-two cases of NAFLD were slected from Jan 2009 to Jan 2012,including 42 cases with combined metformin and rosiglitazone treatmentgroup,and 42 cases with metformin only group.The therapeutic effects were evaluated 6 months after treatments without other hepatoprotective means Results Based on NAFLD images and the serum biochemical related indicators,The combined treatment of metformin and rosiglitation was significantly better than metformin alone(P0.05).Conclusion metformin and insulin sensitizer rosiglitazone in the treatment of NAFLD could have better clinical outcomes with safety.
Publication Year: 2012
Publication Date: 2012-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot